BRIEF-Inovio Reports First Quarter 2026 Financial Results And Recent Business Highlights

Inovio Pharmaceuticals

Inovio Pharmaceuticals

INO

0.00

May 13 (Reuters) - Inovio Pharmaceuticals Inc INO.O:

  • INOVIO REPORTS FIRST QUARTER 2026 FINANCIAL RESULTS AND RECENT BUSINESS HIGHLIGHTS

  • INOVIO PHARMACEUTICALS INC - FDA ACTIVELY REVIEWING INO-3107 BLA UNDER ACCELERATED APPROVAL WITH PDUFA DATE OCT 30, 2026

  • INOVIO PHARMACEUTICALS INC - ANTICIPATES CASH WILL FUND OPERATIONS INTO Q1 2027, BEYOND PDUFA DATE

Source text: ID:nPn2Fl4K7a

Further company coverage: INO.O


This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.